These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17134608)

  • 1. [Stimulation with 0,3 mg recombinant human thyrotropin (rhTSH) increases the effect of 131I therapy in patients with nontoxic nodular goiter. A prospective, randomized, double-blind trial--secondary publication].
    Nielsen VE; Bonnema SJ; Jørgensen HB; Grupe P; Hegedüs L
    Ugeskr Laeger; 2006 Nov; 168(47):4098-101. PubMed ID: 17134608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
    Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L
    J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter.
    Bonnema SJ; Hegedüs L
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):379-84. PubMed ID: 19623060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
    Bonnema SJ; Nielsen VE; Hegedüs L
    Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial.
    Nielsen VE; Bonnema SJ; Boel-Jørgensen H; Grupe P; Hegedüs L
    Arch Intern Med; 2006 Jul; 166(14):1476-82. PubMed ID: 16864757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.
    Fast S; Hegedüs L; Grupe P; Nielsen VE; Bluhme C; Bastholt L; Bonnema SJ
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial.
    Bonnema SJ; Nielsen VE; Boel-Jørgensen H; Grupe P; Andersen PB; Bastholt L; Hegedüs L
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3424-8. PubMed ID: 17566091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter.
    Fast S; Nielsen VE; Grupe P; Boel-Jørgensen H; Bastholt L; Andersen PB; Bonnema SJ; Hegedüs L
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2653-60. PubMed ID: 22577172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial.
    Nielsen VE; Bonnema SJ; Boel-Jørgensen H; Veje A; Hegedüs L
    J Clin Endocrinol Metab; 2005 Jan; 90(1):79-83. PubMed ID: 15494456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
    Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
    Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
    Cubas ER; Paz-Filho GJ; Olandoski M; Goedert CA; Woellner LC; Carvalho GA; Graf H
    Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial.
    Nielsen VE; Bonnema SJ; Hegedüs L
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1317-22. PubMed ID: 16434453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine plus recombinant human thyrotropin do not cause acute airway compression and are effective in reducing multinodular goiter.
    Albino CC; Graf H; Paz-Filho G; Diehl LA; Olandoski M; Sabbag A; Buchpiguel C
    Braz J Med Biol Res; 2010 Mar; 43(3):303-9. PubMed ID: 20401438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study.
    Taïeb D; Sebag F; Cherenko M; Baumstarck-Barrau K; Fortanier C; Farman-Ara B; De Micco C; Vaillant J; Thomas S; Conte-Devolx B; Loundou A; Auquier P; Henry JF; Mundler O
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):115-23. PubMed ID: 18803678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy.
    Bonnema SJ; Fast S; Hegedüs L
    Endocrine; 2011 Dec; 40(3):344-53. PubMed ID: 21971931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human thyrotropin stimulated
    Tang L; Ma T; Wu F
    Nuklearmedizin; 2016 Dec; 55(6):228-235. PubMed ID: 27480576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine ablation of post-surgical thyroid remnants after preparation with recombinant human TSH: why, how and when.
    Barbaro D; Boni G
    Eur J Surg Oncol; 2007 Jun; 33(5):535-40. PubMed ID: 17337154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with Multinodular Goiters: A Meta-Analysis of Randomized Controlled Trials.
    Xu C; Wang P; Miao H; Xie T; Zhou X; Zhang Q; Jiang S; Zhang R; Liao L; Dong J
    Horm Metab Res; 2020 Dec; 52(12):841-849. PubMed ID: 32961564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of diagnostic radioiodine scintigraphy and thyroglobulin measurements after rhTSH injection.
    Verburg FA; de Keizer B; de Klerk JM; Lentjes EG; Lips CJ; van Isselt JW
    Nuklearmedizin; 2009; 48(1):26-9. PubMed ID: 19212608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.